Nicolas U. Gerber

4.3k total citations
63 papers, 1.3k citations indexed

About

Nicolas U. Gerber is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Nicolas U. Gerber has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 28 papers in Neurology and 23 papers in Molecular Biology. Recurrent topics in Nicolas U. Gerber's work include Glioma Diagnosis and Treatment (44 papers), Neuroblastoma Research and Treatments (25 papers) and Chromatin Remodeling and Cancer (8 papers). Nicolas U. Gerber is often cited by papers focused on Glioma Diagnosis and Treatment (44 papers), Neuroblastoma Research and Treatments (25 papers) and Chromatin Remodeling and Cancer (8 papers). Nicolas U. Gerber collaborates with scholars based in Switzerland, Germany and United States. Nicolas U. Gerber's co-authors include Stefan Rutkowski, Katja von Hoff, Torsten Pietsch, Monika Warmuth‐Metz, Frank Deinlein, Martin Benesch, Michael A. Grotzer, André O. von Bueren, Rolf‐Dieter Kortmann and Joachim Kuehl and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Nicolas U. Gerber

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas U. Gerber Switzerland	17	853	620	361	204	142	63	1.3k
Carl P. Boesel United States	19	553 0.6×	446 0.7×	418 1.2×	275 1.3×	90 0.6×	36	1.6k
Anu Banerjee United States	16	597 0.7×	282 0.5×	355 1.0×	152 0.7×	74 0.5×	32	956
Cory Adamson United States	18	578 0.7×	410 0.7×	418 1.2×	190 0.9×	215 1.5×	24	1.4k
Beatrice Melin Sweden	21	700 0.8×	533 0.9×	117 0.3×	270 1.3×	316 2.2×	66	1.6k
Adam L. Green United States	19	283 0.3×	376 0.6×	153 0.4×	121 0.6×	91 0.6×	55	923
Eric Lipp United States	19	488 0.6×	246 0.4×	139 0.4×	186 0.9×	152 1.1×	85	940
Yazmín Odia United States	20	569 0.7×	446 0.7×	174 0.5×	217 1.1×	195 1.4×	89	1.2k
Araz Marachelian United States	17	187 0.2×	379 0.6×	475 1.3×	89 0.4×	221 1.6×	54	943
José Piquer Spain	14	264 0.3×	310 0.5×	149 0.4×	76 0.4×	142 1.0×	35	940
Cassie Kline United States	13	446 0.5×	200 0.3×	202 0.6×	134 0.7×	155 1.1×	64	670

Countries citing papers authored by Nicolas U. Gerber

Since Specialization

Citations

This map shows the geographic impact of Nicolas U. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas U. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas U. Gerber more than expected).

Fields of papers citing papers by Nicolas U. Gerber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas U. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas U. Gerber. The network helps show where Nicolas U. Gerber may publish in the future.

Co-authorship network of co-authors of Nicolas U. Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas U. Gerber. A scholar is included among the top collaborators of Nicolas U. Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas U. Gerber. Nicolas U. Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moreno, Lucas, Pierre Teira, James M. Croop, et al.. (2023). A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors. Frontiers in Pediatrics. 11. 1183295–1183295. 5 indexed citations

Mueller, Timothy, Sandra Laternser, Ana Guerreiro Stücklin, et al.. (2022). Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience. European Journal of Cancer. 178. 171–179. 8 indexed citations

Otth, Maria, Gisela Michel, Nicolas U. Gerber, et al.. (2022). Educational Attainment and Employment Outcome of Survivors of Pediatric CNS Tumors in Switzerland—A Report from the Swiss Childhood Cancer Survivor Study. Children. 9(3). 411–411. 6 indexed citations

Hagel, Christian, Martin Mynarek, Denise Obrecht, et al.. (2022). Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial. European Journal of Cancer. 164. 30–38. 7 indexed citations

Hengartner, Heinz, Raimund Kottke, Sandra P. Toelle, et al.. (2022). Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome. Journal of Pediatric Hematology/Oncology. 45(4). e543–e546. 1 indexed citations

Gerber, Nicolas U., Maria Otth, Katrin Scheinemann, et al.. (2022). Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes. Journal of Neuro-Oncology. 157(2). 307–317. 7 indexed citations

Gessi, Marco, Nicolas U. Gerber, Carsten Friedrich, et al.. (2021). Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro-Oncology. 24(1). 127–137. 9 indexed citations

Perreault, Martin, et al.. (2021). Synthesis and biological evaluation of novel 1,4-benzodiazepin-3-one derivatives as potential antitumor agents against prostate cancer. Bioorganic & Medicinal Chemistry. 45. 116314–116314. 3 indexed citations

Amoroso, Loredana, Victoria Castel, Gianni Bisogno, et al.. (2020). Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network. European Journal of Cancer. 135. 89–97. 15 indexed citations

10.

Warmuth‐Metz, Monika, Brigitte Bison, Nicolas U. Gerber, et al.. (2013). Bone Involvement in Atypical Teratoid/Rhabdoid Tumors of the CNS. American Journal of Neuroradiology. 34(10). 2039–2042. 16 indexed citations

11.

Friedrich, Carsten, André O. von Bueren, Katja von Hoff, et al.. (2012). Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro-Oncology. 15(2). 224–234. 55 indexed citations

12.

Bueren, André O. von, Christoph Oehler, Tarek Shalaby, et al.. (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer. 11(1). 74–74. 20 indexed citations

13.

Bueren, André O. von, Tarek Shalaby, Davide Sciuscio, et al.. (2010). Expression of O6-methylguanine-DNA methyltransferase in childhood medulloblastoma. Journal of Neuro-Oncology. 103(1). 59–69. 10 indexed citations

14.

Pfister, Stefan M., Marc Remke, Axel Benner, et al.. (2009). Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci. Journal of Clinical Oncology. 27(10). 1627–1636. 198 indexed citations

15.

Rutkowski, Stefan, Nicolas U. Gerber, Katja von Hoff, et al.. (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncology. 11(2). 201–210. 107 indexed citations

16.

Hoff, Katja von, Wolfgang Hartmann, André O. von Bueren, et al.. (2009). Large cell/anaplastic medulloblastoma: Outcome according to myc status, histopathological, and clinical risk factors. Pediatric Blood & Cancer. 54(3). 369–376. 51 indexed citations

17.

Bergthaler, Andreas, Nicolas U. Gerber, Doron Merkler, et al.. (2006). Envelope Exchange for the Generation of Live-Attenuated Arenavirus Vaccines. PLoS Pathogens. 2(6). e51–e51. 20 indexed citations

18.

Inskeep, Philip B., Robert A. Ronfeld, Michael J. Peterson, & Nicolas U. Gerber. (1994). Pharmacokinetics of the Aldose Reductase Inhibitor, Zopolrestat, in Humans. The Journal of Clinical Pharmacology. 34(7). 760–766. 22 indexed citations

19.

Falkner, Fred C., Thomas M. Twomey, Dyal C. Garg, et al.. (1990). Disposition of ampiroxicam, a prodrug of piroxicam, in man. Xenobiotica. 20(6). 645–652. 11 indexed citations

20.

Gerber, Nicolas U., D C Mays, Atul Laddu, et al.. (1988). Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of Phenytoin. The Journal of Clinical Pharmacology. 28(11). 1023–1032. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact